JPWO2021035179A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021035179A5 JPWO2021035179A5 JP2022510971A JP2022510971A JPWO2021035179A5 JP WO2021035179 A5 JPWO2021035179 A5 JP WO2021035179A5 JP 2022510971 A JP2022510971 A JP 2022510971A JP 2022510971 A JP2022510971 A JP 2022510971A JP WO2021035179 A5 JPWO2021035179 A5 JP WO2021035179A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- receptor
- composition
- pharmaceutical composition
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962889963P | 2019-08-21 | 2019-08-21 | |
| US62/889,963 | 2019-08-21 | ||
| PCT/US2020/047503 WO2021035179A1 (fr) | 2019-08-21 | 2020-08-21 | Compositions et méthodes de traitement de maladies neurologiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545226A JP2022545226A (ja) | 2022-10-26 |
| JPWO2021035179A5 true JPWO2021035179A5 (fr) | 2023-08-29 |
Family
ID=72356519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510971A Pending JP2022545226A (ja) | 2019-08-21 | 2020-08-21 | 神経学的疾患のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220348635A1 (fr) |
| EP (1) | EP4017874A1 (fr) |
| JP (1) | JP2022545226A (fr) |
| CN (1) | CN114746450A (fr) |
| AU (1) | AU2020334147A1 (fr) |
| CA (1) | CA3151920A1 (fr) |
| WO (1) | WO2021035179A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023092055A1 (fr) * | 2021-11-19 | 2023-05-25 | President And Fellows Of Harvard College | Éléments régulateurs de gènes spécifiques de nocicepteurs pour le traitement de la douleur |
| WO2023147590A2 (fr) * | 2022-01-31 | 2023-08-03 | Howard Hughes Medical Institute | Canaux ioniques modifiés sensibles à un ligand et méthodes d'utilisation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013365A1 (fr) | 1993-11-09 | 1995-05-18 | Targeted Genetics Corporation | Production de titres eleves de vecteurs d'aav recombinants |
| FR2756297B1 (fr) | 1996-11-22 | 1999-01-08 | Centre Nat Rech Scient | Procede de production de virus recombinants |
| AU8672198A (en) | 1997-07-31 | 1999-02-22 | Chiron Corporation | Method enabling readministration of aav vector via immunosuppression of host |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CA2830694C (fr) | 1997-09-05 | 2018-02-27 | Genzyme Corporation | Procedes de generation de preparations de vecteurs de aav recombinants dont le titre est eleve et qui sont exemptes de virus assistant |
| US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CA2348382C (fr) | 1998-11-10 | 2013-09-17 | The University Of North Carolina At Chapel Hill | Vecteurs de papirovirus chimeriques et procedes de production et d'administration connexes |
| US6498244B1 (en) | 1999-05-28 | 2002-12-24 | Cell Genesys, Inc. | Adeno-associated virus capsid immunologic determinants |
| WO2001023001A2 (fr) | 1999-09-29 | 2001-04-05 | The Trustees Of The University Of Pennsylvania | Procedes de modification rapide du peg de vecteurs viraux, compositions servant a ameliorer la transduction de genes, compositions presentant une stabilite physique augmentee, et leurs utilisations |
| TW200412942A (en) | 2002-08-06 | 2004-08-01 | Abbott Lab | Appetite control method |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| WO2005072364A2 (fr) | 2004-01-27 | 2005-08-11 | University Of Florida | Systeme d'expression baculovirus modifie utilise pour la production d'un vecteur raav pseudotype |
| WO2018175443A1 (fr) * | 2017-03-20 | 2018-09-27 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thérapies géniques ciblées pour le traitement de la douleur et d'autres troubles se rapportant au système nerveux |
| AU2018364738A1 (en) * | 2017-11-10 | 2020-05-28 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
| MX2020005470A (es) * | 2017-11-27 | 2020-11-09 | Coda Biotherapeutics Inc | Composiciones y metodos para enfermedades neurologicas. |
-
2020
- 2020-08-21 CA CA3151920A patent/CA3151920A1/fr active Pending
- 2020-08-21 US US17/636,235 patent/US20220348635A1/en active Pending
- 2020-08-21 AU AU2020334147A patent/AU2020334147A1/en active Pending
- 2020-08-21 WO PCT/US2020/047503 patent/WO2021035179A1/fr unknown
- 2020-08-21 JP JP2022510971A patent/JP2022545226A/ja active Pending
- 2020-08-21 EP EP20767671.9A patent/EP4017874A1/fr active Pending
- 2020-08-21 CN CN202080067794.7A patent/CN114746450A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7482549B2 (ja) | 新規のマイクロジストロフィンおよび使用の関連する方法 | |
| JP2019089787A5 (fr) | ||
| RU2017121593A (ru) | Векторы aav, нацеленные на центральную нервную систему | |
| RU2020113681A (ru) | Капсиды вариантов аденоассоциированных вирусов и методы их применения | |
| JP2019537437A5 (fr) | ||
| JP2021503960A5 (fr) | ||
| JP2018503374A5 (fr) | ||
| RU2020108189A (ru) | Композиции и способы лечения бокового амиотрофического склероза (als) | |
| EP2933335A1 (fr) | Procédé de traitement de neuropathies périphériques et sclérose latérale amyotrophique | |
| RU2018129159A (ru) | Рекомбинантные aav векторы, экспрессирующие остеопротективные гены, включая has2 и лубрицин, пригодные при лечении остеоартрита и сходных заболеваний суставов у млекопитающих | |
| US20240018521A1 (en) | Compositions and methods comprising engineered short nuclear rna (snrna) | |
| US20230321277A1 (en) | Novel polynucleotides encoding a human fkrp protein | |
| RU2018145010A (ru) | Оптимизированные гены и экспрессионные кассеты cln1, и их применение | |
| JPWO2021035179A5 (fr) | ||
| CN114040974A (zh) | 用于高效rna反式剪接的三螺旋终止子 | |
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| Flytzanis et al. | Broad gene expression throughout the mouse and marmoset brain after intravenous delivery of engineered AAV capsids | |
| JP2019524090A5 (fr) | ||
| EP3419673B1 (fr) | Thérapie génique pour le traitement d'une maladie des cellules cônes de la rétine | |
| AU2016337034A1 (en) | Antisense oligonucleotides for use in treating Alzheimer's disease | |
| US20220370640A1 (en) | Gene therapy expression system alleviating cardiac toxicity of fkrp | |
| JPWO2022040535A5 (fr) | ||
| JPWO2020069461A5 (fr) | ||
| US20190202908A1 (en) | Bi-specific agents | |
| IL273538B1 (en) | Anti-TRKB Monoclonal Antibodies and Methods of Use |